Cohance Lifesciences Receives MCA Approval for Umang Vohra as Chairman and Group CEO
Cohance Lifesciences receives MCA approval for Umang Vohra as Chairman and Group CEO. Leadership transition follows a Q1 revenue of ₹422.26 Cr and net loss.
Monday, 12 October 2026
NSE & BSE filings, as they land
ALFA News
Straight from the exchange filing